TCRT

1.6906.29%
RW

Robert W. Postma

Independent Director

Mr. Robert W. Postma, also known as Bob, serves as Independent Director of Alaunos Therapeutics, Inc. (formerly known as ZIOPHARM Oncology, Inc.) since February 05, 2021. Mr. Postma has served as the principal of WaterMill Asset Management Corporation, an asset management firm which he founded in July 1999 that actively trades in municipal bonds and equities. Mr. Postma has valuable relationships with prospective financial partners and has a strong ownership perspective to Ziopharm’s boardroom, as WaterMill is one of the largest, long-term shareholders of the Company. In addition, he has experience investing across the equity and fixed income markets and frequently analyzes, invests in and engages with healthcare and biotechnology companies. Mr. Postma holds a Bachelor of Arts degree in Business and Economics from Lafayette College.

Positions